Icon
+91 94997 68112
Login Register

Exforge HCT - (5/10MG; 12.5/25MG; 160/320MG,10MG; Tablet)

Amlodipine, Hydrochlorothiazide and Valsartan Novartis
5/10MG; 12.5/25MG; 160/320MG,10MG; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated for the treatment of hypertension, to lower blood pressure.
Yes
**** *** ******* *** ****** ** *****. ** **** **, **** **** ***** ***** **** ** *** *** ********* ** ********. ***** ***** *** ******* **** ***** **** ** *** *** **** ******. ******** *** *** **** * **** ******* ***** & ******* ** ***** ***** ****** ** ****** **** *** ************ ** ***(*)(*)(*)(**)(**) ** *** **** ** *** ***** ********* **** ****** *********** ***** ***** ******* ********, ***** ***********, ****** ** ***********, ** ******* ** ***. **** * *** ****** '*** *** ****** ** ********, ****, ******* *** ***** ***** **** ** **** *** **** *** **** *********. ******* ********** *** ********* **** *** *** ***** ********* ********* ** *** ***** ** ***** **** ******** *** ******* ** *** ****. *** ****** ***** ****, ***** *** ******* ******** *** *******.
Exforge HCT Patent 1 Patent 2 Patent 3
**** *** ********* *** ********* *** *********
***** ******* ******* *******
******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** ** *** ********* ******** ******** ** *** **, ****
***** ** \ ** *** **, **** ******* ******** ******** ** *** *, ****
******* ** \ ** *** **, **** ******* ******** ******** ** *** *, ****
  1. **** **, **** : ***** **** ** *** ***** **** ********** *** ** *** ** ****. ******** *** *** **** *** **** ******* ****.
  2. *** *, **** : ***** ******** ******** ***** *** **** ** **** ****** '***. *** **** ** ******* ***-************ ** ****** '***. ******** *** *** **** * **** ******* ***** ******** **** *****'* **** ****** ** ****** **** *** ************ ** ***(*)(*)(*)(**)(**) ** *** **** ** ** ********* **** ****** *********** ***** *****'* ******* ********, ***** ***********, ****** ** ***********, ** ******* ** ***.
  3. *** *, **** : ******* ******** ******** ***** *** **** ** **** ****** '*** (*** **, ****).
  4. *** **, **** : ****** '*** (*** **, ****) *** ****** ** ******** *** *** ************ ****** ** *** **********.
  5. *** *, **** : ******* ******** ******** ***** *** **** ** **** ****** '***. *** **** ** ******* ***-************ ** ****** '***. ******** *** *** **** * **** ******* ******* ******** **** *******'* **** ****** ** ****** **** *** ************ ** ***(*)(*)(*)(**)(**) ** *** **** ** ** ********* **** ****** *********** ***** *****'* ******* ********, ***** ***********, ****** ** ***********, ** ******* ** ***.
  6. *** **, **** : ******** ***** * **** ******* ***** & ******* *** ****** '*** & '*** ** ******** ***** ** ** & ******** ***** ** ******** ************.
  7. **** **, **** : ********** *** ********* **** **** ***** *** ***** ** ********* *** *** *****. **** **** ***** ******** *** *** *** ****** *** *******.
  8. *** *, **** : ********** *** ********* **** ***** *** ******* ***** *** ***** ** ********* *** *** *****.
  9. *** *, **** : ***** *** ******* ******** *** *******.
  10. *** **, **** : **** ******** *** *******.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.